Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05507814 · ClinicalTrials.gov registry record · NA

Temporal Window and Episodic Future Thinking in CUD

A NA study of Cocaine Use Disorder, sponsored by Virginia Polytechnic Institute and State University.

Completed
Registry status
NA
Development phase
141
Enrollment target
1
Study location

NCT05507814 is a NA study of Cocaine Use Disorder that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 141 participants, above the 98-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05507814, a NA study of Cocaine Use Disorder, has completed, sponsored by Virginia Polytechnic Institute and State University.

COMPLETED
Registry status
NA
Development phase
141 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to test the theory of Reinforcer Pathology via manipulation of the temporal window with successive Episodic Future Thinking generation in individuals with cocaine use disorder.

Conditions Studied

Interventions

  • BEHAVIORAL Episodic Future Thinking (EFT)
  • BEHAVIORAL Control Episodic Thinking

Study Locations (1)

Virginia

  • Fralin Biomedical Research Institute at VTC - Roanoke

Trial Details

FieldValue
Enrollment Target 141 participants
Start Date 2022-11-30
Est. Completion 2025-11-24
Phase NA

What the Registry Record Tells You About NCT05507814

The ClinicalTrials.gov registry entry for NCT05507814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (44% higher). The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Episodic Future Thinking (EFT) is the first listed.

NCT05507814 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05507814 about?

NCT05507814 is a clinical study titled "Temporal Window and Episodic Future Thinking in CUD". The primary objective is to test the theory of Reinforcer Pathology via manipulation of the temporal window with successive Episodic Future Thinking generation in individuals with cocaine use disorder.

What is the current status of trial NCT05507814?

This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2022-11-30. Estimated completion is 2025-11-24.

What conditions does trial NCT05507814 study?

This clinical trial studies the following conditions: Cocaine Use Disorder.

What interventions are being tested in trial NCT05507814?

The interventions under investigation include: Episodic Future Thinking (EFT) (BEHAVIORAL), Control Episodic Thinking (BEHAVIORAL).

Who is sponsoring clinical trial NCT05507814?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05507814 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cocaine Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.